Itziar Erkizia

Badalona, CT, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 26 publications

Optimized ACE2-Fc fusion proteins with picomolar neutralization activity against highly evolved SARS-CoV-2 variants.

Optimized ACE2-Fc fusion proteins with picomolar neutralization activity against highly evolved SARS-CoV-2 variants.

Journal: Protein science : a publication of the Protein Society

Published: October 17, 2025

Highly Efficient Air Sterilization via Low-Temperature Interfacial Evaporation in Inductively Heated Superhydrophilic Ferromagnetic Filters.

Highly Efficient Air Sterilization via Low-Temperature Interfacial Evaporation in Inductively Heated Superhydrophilic Ferromagnetic Filters.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: May 20, 2025

Isolation and structure elucidation of Dm-CVNH, a new cyanovirin-N homolog with activity against SARS-CoV-2 and HIV-1.

Isolation and structure elucidation of Dm-CVNH, a new cyanovirin-N homolog with activity against SARS-CoV-2 and HIV-1.

Journal: The Journal of biological chemistry

Published: December 19, 2024

Massive endocytosis mechanisms are involved in uptake of HIV-1 particles by monocyte-derived dendritic cells.

Massive endocytosis mechanisms are involved in uptake of HIV-1 particles by monocyte-derived dendritic cells.

Journal: Frontiers in immunology

Published: October 03, 2024

Targeting eEF1A reprograms translation and uncovers broad-spectrum antivirals against cap or m6A protein synthesis routes.

Targeting eEF1A reprograms translation and uncovers broad-spectrum antivirals against cap or m6A protein synthesis routes.

Journal: Nature communications

Published: June 11, 2024

Proteomics of circulating extracellular vesicles reveals diverse clinical presentations of COVID-19 but fails to identify viral peptides.

Proteomics of circulating extracellular vesicles reveals diverse clinical presentations of COVID-19 but fails to identify viral peptides.

Journal: Frontiers in cellular and infection microbiology

Published: June 02, 2024

Host genetic and immune factors drive evasion of HIV-1 pathogenesis in viremic non-progressors.

Host genetic and immune factors drive evasion of HIV-1 pathogenesis in viremic non-progressors.

Journal: Med (New York, N.Y.)

Published: March 13, 2024

Preclinical development of humanized monoclonal antibodies against CD169 as a broad antiviral therapeutic strategy.

Preclinical development of humanized monoclonal antibodies against CD169 as a broad antiviral therapeutic strategy.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: January 16, 2024

Impact of Obefazimod on Viral Persistence, Inflammation, and Immune Activation in People With Human Immunodeficiency Virus on Suppressive Antiretroviral Therapy.

Impact of Obefazimod on Viral Persistence, Inflammation, and Immune Activation in People With Human Immunodeficiency Virus on Suppressive Antiretroviral Therapy.

Journal: The Journal of infectious diseases

Published: February 06, 2023

Author Correction to: SARS-CoV-2 interaction with Siglec-1 mediates trans-infection by dendritic cells.

Author Correction to: SARS-CoV-2 interaction with Siglec-1 mediates trans-infection by dendritic cells.

Journal: Cellular & molecular immunology

Published: July 13, 2022

Actin-regulated Siglec-1 nanoclustering influences HIV-1 capture and virus-containing compartment formation in dendritic cells.

Actin-regulated Siglec-1 nanoclustering influences HIV-1 capture and virus-containing compartment formation in dendritic cells.

Journal: eLife

Published: March 22, 2022

SARS-CoV-2 interaction with Siglec-1 mediates trans-infection by dendritic cells.

SARS-CoV-2 interaction with Siglec-1 mediates trans-infection by dendritic cells.

Journal: Cellular & molecular immunology

Published: October 08, 2021

Showing 1-12 of 26

Last Updated: 09/26/2026